Pharmacokinetics of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ, NSC 224070) during a phase I clinical trial

Autor: Betteridge, Richard F., Bosanquet, Andrew G., Gilby, Edward D.
Zdroj: In European Journal of Cancer and Clinical Oncology 1990 26(2):107-112
Databáze: ScienceDirect